Man et al. showed that HT improves glioma stem-like cell (GSC) radiosensitivity by inhibiting AKT proliferative and pro-survival signaling by identifying the survival kinase AKT as a crucial sensitization factor for GSCs [83]. Here, AKT1 is linked to glioma.